A Study to Evaluate the Effect of BMS-955176 on Pharmacokinetics of Dolutegravir and the Effect of Dolutegravir on the Pharmacokinetics of BMS-955176

Clinical trial NCT02715479 · COMPLETED

Trial details

NCT number: NCT02715479
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus

Start date: 2016-04-01
Primary completion: 2016-05-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.